XML 14 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
BALANCE SHEETS - USD ($)
Sep. 30, 2017
Sep. 30, 2016
CURRENT ASSETS:    
Cash and cash equivalents $ 2,369,438 $ 2,917,996
Receivables 218,481 394,515
Prepaid expenses 826,429 981,677
Deposits - current portion 150,000 154,995
Inventory used for R&D and manufacturing 672,522 1,008,642
Total current assets 4,236,870 5,457,825
Plant, property and equipment 16,793,220 17,350,836
Patent costs, net 223,167 256,547
Deposits 1,670,917 1,820,917
Total Assets 22,924,174 24,886,125
CURRENT LIABILITIES:    
Accounts payable 8,196,334 3,091,512
Accrued expenses 936,698 378,672
Due to employees 693,831 538,278
Notes payable, net of discounts 994,258 0
Derivative instruments, current portion 10,984 0
Other current liabilities 12,449 3,310
Total current liabilities 10,844,554 4,011,772
Derivative instruments, net of current portion 2,042,418 8,394,934
Lease liability 13,211,925 13,011,023
Deferred revenue 125,000 125,000
Other liabilities 37,254 22,609
Total liabilities 26,261,151 25,565,338
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' DEFICIT    
Preferred stock, $.01 par value- 200,000 shares authorized; -0- shares issued and outstanding 0 0
Common stock, $.01 par value - 600,000,000 shares authorized; 11,903,133 and 6,248,035 shares issued and outstanding at September 30, 2017 and 2016, respectively 119,031 62,480
Additional paid-in capital 296,298,401 284,649,429
Accumulated deficit (299,754,409) (285,391,122)
Total stockholders' deficit (3,336,977) (679,213)
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY $ 22,924,174 $ 24,886,125